HomePATELRMART › Filing
🔔 Get instant alerts when PATELRMART files quarterly results on BSE Start free trial →
Patel Retail Limited (PATELRMART)

Monitoring Agency Report for the Quarter ended on June30,2026.

Filed: 12 Aug 2026, 13:16 IST Exchange: BSE Category: Regulatory Compliance — Monitoring Agency Report
Monitoring Agency report for Q1 FY2027 confirms no material deviation in IPO proceeds utilization. - Total issue size INR 242.658 Cr; net proceeds INR 189.2101 Cr after expenses - Offer related expenses increased by INR 1.2686 Cr, revising General Corporate Purpose amount - Utilization aligned with objects: repayment, working capital, corporate purposes - Unutilized IPO proceeds INR 12.9475 Cr as of June 30, 2026 - No delays reported; capex ongoing as per schedule - Monitoring Agency: ICRA Limited; report dated Aug 12, 2026
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 PATELRMART — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add PATELRMART to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Patel Retail Limited

Important. The summary above is generated automatically from Patel Retail Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.